Sodium arsenite alters cell cycle and MTHFR, MT1/2, and c-Myc protein levels in MCF-7 cells

Toxicology and Applied Pharmacology

Volumn 241, Issue 3, 2009, Pages 269-274

  Ruiz Ramos, Ruben ^a,b   López Carrillo, Lizbeth ^a   Albores, Arnulfo ^b   Hernández Ramírez, Raúl U ^a   Cebrian, Mariano E ^b  

^a INSTITUTO NACIONAL DE SALUD PÚBLICA   (Mexico)

^b DEPARTAMENTO DE FÍSICA   (Mexico)

Author keywords

Arsenic; c Myc; Cell cycle; MCF 7 cells; MT1 2; MTHFR

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); ARSENITE SODIUM; DIHYDROFOLATE REDUCTASE; METALLOTHIONEIN I; METALLOTHIONEIN II; MYC PROTEIN;

ARTICLE; BREAST CANCER; CANCER RISK; CELL CYCLE S PHASE; CELL PROLIFERATION; CELL STRAIN MCF 7; CELL VIABILITY; CHEMICAL CARCINOGENESIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA SYNTHESIS; GROWTH REGULATION; HUMAN; HUMAN CELL; PROTEIN EXPRESSION;

ANTIMETABOLITES; ARSENITES; BLOTTING, WESTERN; BROMODEOXYURIDINE; CELL CYCLE; CELL LINE, TUMOR; CELL SURVIVAL; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; HUMANS; METALLOTHIONEIN; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); PROTO-ONCOGENE PROTEINS C-MYC; S PHASE; SODIUM COMPOUNDS;

EID: 70350610649     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2009.09.006     Document Type: Article

References (30)

1. Abdel-Mageed A., and Agrawal K.C. Antisense down-regulation of metallothionein induces growth arrest and apoptosis in human breast carcinoma cells. Cancer Gene Ther. 4 (1997) 199-207
2. Abdel-Mageed A., and Agrawal K.C. Activation of nuclear factor κB: potential role in metallothionein-mediated mitogenic response. Cancer Res. 58 (1998) 2335-2338
3. ATSDR. Toxicological Profile for Arsenic. Agency for Toxic Substances and Disease Registry (2007), U.S. Department of Health and Human Services, Atlanta, GA
4. Baylin S.B., Hennan J.G., Graff J.R., Vertino P.M., and Issa J.P. Alterations in DNA methylation: a fundamental aspect of neoplasia. Adv. Cancer Res. 72 (1998) 141-196
5. Chern C.L., Huang R.F.S., Chen Y.H., Cheng J.T., and Liu T.Z. Folate deficiency-induced oxidative stress and apoptosis are mediated via homocysteine-dependent overproduction of hydrogen peroxide and enhanced activation of NF-kappaB in human Hep G2 cells. Biomed. Pharmacother. 55 (2001) 434-442
6. Chen H., Liu J., Merrick B.A., and Waalkes M.P. Genetic events associated with arsenic-induced malignant transformation: applications of cDNA microarray technology. Mol. Carcinog. 30 (2001) 79-87
7. Chen H., Liu J., Zhao C.Q., Diwan B.A., Merrick B.A., and Waalkes M.P. Association of c-myc overexpression and hyperproliferation with arsenite-induced malignant transformation. Toxicol. Appl. Pharmacol. 175 (2001) 260-268
8. Cherian M.G., Huang P.C., Klaassen C.D., Liu Y.P., Longfellow D.G., and Waalkes M.P. National Cancer Institute workshop on the possible roles of metallothionein in carcinogenesis. Cancer Res. 53 (1993) 922-925
9. Coppin J.F., Qu W., and Waalkes M.P. Interplay between cellular methyl metabolism and adaptive efflux during oncogenic transformation from chronic arsenic exposure in human cells. J. Biol. Chem. 283 (2008) 19342-19350
10. Das P.M., and Singal R. DNA methylation and cancer. J. Clin. Oncol. 22 (2004) 4632-4642
11. Gurel V., Sens D.A., Somji S., Garrett S.H., Nath J., and Sens M.A. Stable transfection and over-expression of metallothionein isoform 3 inhibits the growth of MCF-7 and Hs578T cells but not that of T-47D or MDA-MB-231 cells. Breast Cancer Res. Treat. 80 (2003) 181-191
12. Gurel V., Sens D.A., Somji S., Garrett S.H., Weiland T., and Sens M.A. Post-transcriptional regulation of metallothionein isoform 1 and 2 expression in the human breast and the MCF-10A cell line. Toxicol. Sci. 85 (2005) 906-915
13. Jin R., Chow V.T., Tan P.H., Dheen S.T., Duan W., and Bay B.H. Metallothionein 2A expression is associated with cell proliferation in breast cancer. Carcinogenesis 23 (2002) 81-86
14. Kitchin K.T., and Wallace K. The role of protein binding of trivalent arsenicals in arsenic carcinogenesis and toxicity. J. Inorg. Biochem. 102 (2008) 532-539
15. Lee T.C., Tanaka N., Lamb P.W., Gilmer T.M., and Barrett J.C. Induction of gene amplification by arsenic. Science 21 (1988) 79-81
16. Liu J., Kadiiska M.B., Liu Y., Lu T., Qu W., and Waalkes M.P. Stress-related gene expression in mice treated with inorganic arsenicals. Toxicol. Sci. 61 (2001) 314-320
17. Lu S., Hoestje S.M., Choo E., and Epner D.E. Induction of caspase-dependent and -independent apoptosis in response to methionine restriction. Int. J. Oncol. 22 (2003) 415-420
18. Nagel W.W., and Valle B.L. Cell cycle regulation of metallothionein in human colonic cancer cells. Proc. Natl. Acad. Sci. U.S.A. 92 (1995) 579-583
19. Pavillard V., Drbal A.A., Swaine D.J., Phillips R.M., Double J.A., and Nicolaou A. Analysis of cell-cycle kinetics and sulfur amino acid metabolism in methionine-dependent tumor cell lines; the effect of homocysteine supplementation. Biochem. Pharmacol. 67 (2004) 1587-1599
20. Ruiz-Ramos R., Lopez-Carrillo L., Rios-Perez A.D., De Vizcaya-Ruíz A., and Cebrian M.E. Sodium arsenite induces ROS generation, DNA oxidative damage, HO-1 and c-Myc proteins, NF-κB activation and cell proliferation in human breast cancer MCF-7 cells. Mutat. Res. 674 (2009) 109-115
21. Schläwicke Engström K., Broberg K., Concha G., Nermell B., Warholm M., and Vahter M. Genetic polymorphisms influencing arsenic metabolism: evidence from Argentina. Environ. Health Perspect. 115 (2007) 599-605
22. Sekhon J., Pereira P., Sabbaghian N., Schievella A.R., and Rozen R. Antisense inhibition of methylenetetrahydrofolate reductase reduces survival of methionine-dependent tumor lines. Brit. J. Cancer 87 (2002) 225-230
23. Shimizu M., Hochadel J.F., Fulmer B.A., and Waalkes M.P. Effect of glutathione depletion and metallothionein gene expression on arsenic-induced cytotoxicity and c-myc expression in vitro. Toxicol. Sci. 45 (1998) 204-211
24. Stankova J., Shang J., and Rozen R. Antisense inhibition of methylenetetrahydrofolate reductase reduces cancer cell survival in vitro and tumor growth in vivo. Clin. Cancer Res. 11 (2005) 2047-2052
25. Steinmaus C., Moore L.E., Shipp M., Kalman D., Rey O.A., Biggs M.L., Hopenhayn C., Bates M.N., Zheng S., Wiencke J.K., and Smith A.H. Genetic polymorphisms in MTHFR 677 and 1298, GSTM1 and T1, and metabolism of arsenic. J. Toxicol. Environ. Health A. 70 (2007) 159-170
26. Trouba K.J., Wauson E.M., and Vorce R.L. Sodium arsenite-induced dysregulation of proteins involved in proliferative signaling. Toxicol. Appl. Pharmacol. 164 (2000) 161-170
27. Waalkes M.P., Miller M.S., Wilson M.J., Bare R.M., and McDowell A.E. Increased metallothionein gene expression in 5-aza-2′-deoxycytidine-induced resistance to cadmium cytotoxicity. Chem. Biol. Interact. 66 (1988) 189-204
28. Yamada K., Strahler J.R., Andrews P.C., and Matthews R.G. Regulation of human methylenetetrahydrofolate reductase by phosphorylation. Proc. Nat. Acad. Sci. 102 (2005) 10454-10459
29. Ye J., Li A., Liu Q., Wang X., and Zhou J. Inhibition of mitogen-activated protein kinase kinase enhances apoptosis induced by arsenic trioxide in human breast cancer MCF-7 cells. Clin. Exp. Pharmacol. Physiol. 32 (2005) 1042-1048
30. Zhao C.Q., Young M.R., Diwan B.A., Coogan T.P., and Waalkes M.P. Association of arsenic-induced malignant transformation with DNA hypomethylation and aberrant gene expression. Proc. Natl. Acad. Sci. U.S.A. 94 (1997) 10907-10912